Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F ROUSSEL

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
Oncogene|April 5, 2023
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilitiesIrene Paassen, Justin Williams, Carla Ríos Arceo, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumorsRebecca R J Collins, Rebecca R Florke Gee, Maria Camila Hoyos Sanchez, et al.
Bioorganic & Medicinal Chemistry|November 25, 2017
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitorsWilliam R Shadrick, Peter J Slavish, Sergio C Chai, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Genes & Development|November 2, 2005
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formationTamar Uziel, Frederique Zindy, Suqing Xie, et al.
Acta Neuropathologica|June 11, 2020
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resourceKyle S Smith, Ke Xu, Kimberly S Mercer, et al.
Cancer Research|April 22, 2026
A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 MedulloblastomaJake D Friske, Flore Cuisin, Paloma Guernalec, et al.
The Journal of Experimental Medicine|March 9, 2018
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing lossTal Teitz, Jie Fang, Asli N Goktug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Establishing a Preclinical Multidisciplinary Board for Brain TumorsBirgit V Nimmervoll, Nidal Boulos, Brandon Bianski, et al.
Cell Reports|April 7, 2015
Casein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesisClara Penas, Eve-Ellen Govek, Yin Fang, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
Oncogene|April 5, 2023
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilitiesIrene Paassen, Justin Williams, Carla Ríos Arceo, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumorsRebecca R J Collins, Rebecca R Florke Gee, Maria Camila Hoyos Sanchez, et al.
Bioorganic & Medicinal Chemistry|November 25, 2017
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitorsWilliam R Shadrick, Peter J Slavish, Sergio C Chai, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Genes & Development|November 2, 2005
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formationTamar Uziel, Frederique Zindy, Suqing Xie, et al.
Acta Neuropathologica|June 11, 2020
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resourceKyle S Smith, Ke Xu, Kimberly S Mercer, et al.
Cancer Research|April 22, 2026
A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 MedulloblastomaJake D Friske, Flore Cuisin, Paloma Guernalec, et al.
The Journal of Experimental Medicine|March 9, 2018
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing lossTal Teitz, Jie Fang, Asli N Goktug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Establishing a Preclinical Multidisciplinary Board for Brain TumorsBirgit V Nimmervoll, Nidal Boulos, Brandon Bianski, et al.
Cell Reports|April 7, 2015
Casein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesisClara Penas, Eve-Ellen Govek, Yin Fang, et al.
Pageof 31